Year: 2025

Appili Therapeutics to Attend BARDA Innovation Symposium 2025

Written by Customer Service on October 22, 2025. Posted in Public Companies.

Highlights Government-Funded Pipeline and Expanding Role of Public-Private Partnerships in Biodefense Innovation HALIFAX, Nova Scotia, Oct. 22, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTC Pink: APLIF) (“Appili” or the “Company”) today announced that it will attend the Biomedical Advanced Research and Development Authority (BARDA) Innovation Symposium on November 20, 2025, in Washington, D.C. The event brings together leaders from government, industry, and academia to advance the development of medical countermeasures such as vaccines, therapeutics, and diagnostics for public health emergencies including pandemics, antimicrobial resistance, and emerging biological threats. “Government partnerships are central to Appili’s mission and business model. The recent up to US $40 million contract from the National Institute...

Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock

Written by Customer Service on October 22, 2025. Posted in Public Companies.

SAN FRANCISCO, Oct. 22, 2025 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines in oncology and autoimmune disease, today announced the pricing of its underwritten registered offering of 24,485,799 shares of its common stock at a price of $10.21 per share. The gross proceeds to Nurix from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Nurix, are expected to be $250.0 million. The offering is expected to close on or about October 23, 2025, subject to the satisfaction of customary closing conditions. All of the securities are being offered by Nurix. The offering includes participation from both new and existing investors...

Gilat to Report Third Quarter 2025 Results on Wednesday, November 12th

Written by Customer Service on October 22, 2025. Posted in Public Companies.

PETAH TIKVA, Israel, Oct. 22, 2025 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today announced that it will release its third quarter 2025 financial results on Wednesday, November 12, 2025. Conference Call and WebcastFollowing the release, Adi Sfadia, Chief Executive Officer, and Gil Benyamini, Chief Financial Officer, will discuss Gilat’s third quarter 2025 results and business achievements and participate in a question and answer session:Date: Wednesday, November 12, 2025Start: 09:30 AM EST / 16:30 IST A simultaneous webcast of the conference call will be available on the Gilat website at www.gilat.com and through this link: https://www.veidan-conferencing.com/gilatOr Dial-in: US: 1-888-407-2553 International:...

Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million

Written by Customer Service on October 22, 2025. Posted in Public Companies.

Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera’s dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The agreement includes 1) an upfront payment of $3.5 million, 2) potential future regulatory milestones, commercial milestones, and contingent value rights of up to $105 million. Biossil assumes all further obligations to Blackstone Life Sciences under the 2018 Amended and Restated Purchase and Sale Agreement (the Royalty Agreement) for dismutase mimetics products, notably a 4% royalty, should either of these agents reach commercialization. Galera’s lead program remains its pan-inhibitor of Nitric Oxide Synthase (NOS), which is in a multicenter Phase 2 trial in metaplastic breast cancer in combination with alpelisib and nab-paclitaxel. MALVERN,...

Steve Madden Announces Third Quarter 2025 Earnings Release Date

Written by Customer Service on October 22, 2025. Posted in Public Companies.

LONG ISLAND CITY, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) — Steven Madden, Ltd. (NASDAQ: SHOO), a leading designer and marketer of fashion-forward footwear, accessories and apparel, today announced that the Company plans to release its third quarter 2025 earnings results on Wednesday, November 5, 2025. Management will host a conference call to review the results at 8:30 a.m. Eastern Time. The live webcast of the management call can be accessed at the Company’s investor relations website at https://investor.stevemadden.com or by using the following link https://edge.media-server.com/mmc/p/f3725r4k. The webcast is listen-only. Those interested in participating in the question-and-answer session should follow the conference call dial-in instructions below. Participants may register for the conference call here to receive the dial-in...

YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs

Written by Customer Service on October 22, 2025. Posted in Dividend Reports And Estimates.

CHICAGO and MILWAUKEE and NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex. & Record Date: October 23,2025Payment Date: October 24, 2025ETF Ticker1 ETF Name Distribution Frequency Distribution per Share Distribution Rate2,4 30-DaySEC Yield3 ROC5ABNY YieldMax® ABNB Option Income Strategy ETF Weekly $0.1491 77.88% 2.95% 95.71%AIYY YieldMax® AI Option Income Strategy ETF Weekly $0.0288 58.08% 3.88% 78.15%AMDY YieldMax® AMD Option Income Strategy ETF Weekly $0.1900 101.48% 2.01% 0.00%AMZY YieldMax® AMZN Option Income Strategy ETF Weekly $0.0959 35.16% 2.99% 12.46%APLY YieldMax® AAPL Option Income Strategy ETF Weekly $0.1112 42.04% 2.61% 48.29%BABO YieldMax® BABA Option Income Strategy Weekly $0.3095 100.99% 1.79% 93.81%BRKC YieldMax®...

Third Party Logistics Provider CPGIO Uses Descartes’ Ecommerce Inventory and Order Management Solution to Achieve 5x Growth

Written by Customer Service on October 22, 2025. Posted in Public Companies.

ATLANTA, Oct. 22, 2025 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Illinois-based CPGIO, an omnichannel, optimization and fulfillment partner for consumer packaged goods (CPG) companies, is fueling explosive ecommerce growth using Descartes’ inventory and order management solution to synchronize and simplify its multichannel distribution across more than 40 sales channels. By aggregating ecommerce operations on a centralized platform, the cloud-based Descartes solution increased efficiency and visibility to enable CPGIO to scale from 2,000 to 10,000 daily orders. “With more than 600 of the world’s leading CPG brands relying on us to optimize their ecommerce operations, we needed to move beyond the constraints of our legacy...

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Written by Customer Service on October 22, 2025. Posted in Public Companies.

Acquisition aims to strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next milestone in the execution of its oncology strategy CureVac shareholders receive approximately $5.46 in BioNTech American Depositary Shares for each CureVac share, subject to a collar; an indicative exchange ratio will be available at www.envisionreports.com/CureVacOffer for the duration of the exchange offer Information on how CureVac shareholders can participate in the exchange offer is available via Georgeson LLC, the information agent for the exchange offer, at +1 888 686 7195 (toll free in the US), +1 732 353 1948 (collect), or Curevacoffer@georgeson.com Exchange offer will expire at 9:00 a.m. (New York City time) on December 3, 2025, unless extended or terminated earlier,...

Form 8.3 – [NCC GROUP PLC – 21 10 2025] – (CGAML)

Written by Customer Service on October 22, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree NCC GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

Lulus to Report Third Quarter 2025 Results on November 12, 2025

Written by Customer Service on October 22, 2025. Posted in Public Companies.

CHICO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — Lulu’s Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (Nasdaq: LVLU), the attainable luxury brand for women, announced today that the Company will release its third quarter 2025 financial results on Wednesday, November 12, 2025, after market close. The Company will host a conference call and live webcast with the investment community at 5:00 p.m. Eastern Time that same day. The financial results and live webcast will be accessible through the Investor Relations section of the Company’s website at https://investors.lulus.com/. To access the call through a conference line, dial 1-877-407-0792 (in the U.S.) or 1-201-689-8263 (international callers). A replay of the conference call will be posted shortly after the call and will be available for seven days. To access the...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals